A large language model-powered AI assistant developed in Hong Kong has demonstrated high accuracy in thyroid cancer staging and risk classification.A team of researchers from the Li Ka Shing Faculty of Medicine of the…
Continue Reading
Simon Rasalingham, chief executive of Behold.ai (Credit: Prix Galien International)
UK-based digital health start-up Behold.ai has entered administration after failing to win any contracts under the government’s AI Diagnostic Fund.
Behold.ai supplies lung cancer AI…
Researchers at The Clatterbridge Cancer Centre NHS Foundation Trust in Wirral are using AI to enhance the precision of radiotherapy for prostate cancer.
The PIVOTALboost study, which ran from 2018, recently closed after surveying data…
The Hong Kong University of Science and Technology has recently announced its development of four large language models for healthcare.WHAT IT’S ABOUT
Developed out of HKUST SuperPOD, the university’s AI supercomputing facility, the LLM-based tools…
AI biotech company Owkin announced a partnership with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.According to Owkin, BRCA…
Continue Reading
Welcome to the June edition of Digital Health Digest!This month, we're bringing you cutting-edge updates from the digital health world, including breakthroughs in AI for skin cancer detection, direct connectivity of medical devices to…
Continue Reading
By Shania Kennedy
February 08, 2024 – A research team from the University of Texas at Arlington (UTA) has developed an algorithm to provide optimal personalized treatment options for esophageal cancer patients, according to a January…
Continue Reading
The UEF Cancer AI team launched a challenge for estimating breast density from mammograms. Addressing limitations in existing tools, the challenge seeks innovative deep-learning architectures. Participants work with a dataset of 569 mammogram images,…
Continue Reading
What You Should Know:
Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes.Galen Breast HER2 is an AI-powered biomarker…
Continue Reading
